Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HOLOGIC INCHOLX · Entity 12463 | Director | November 13, 2017 | November 15, 2017 |
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Director | May 22, 2019 | May 23, 2019 |
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | June 01, 2019 | June 04, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HOLOGIC INC
Report date November 13, 2017 · Filed November 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,302 |
Last balance in matching sequence
After 2017-11-14 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2017-11-13 · Exercise / conversion · Acquired 9,282 · Balance 33,092 F1: Transaction pursuant to an existing rule 10b5-1 trading plan. F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan. Row 2 · 2017-11-13 · Sale · Disposed 9,282 · Balance 23,810 F1: Transaction pursuant to an existing rule 10b5-1 trading plan. F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan. Row 3 · 2017-11-14 · Exercise / conversion · Acquired 3,492 · Balance 27,302 F1: Transaction pursuant to an existing rule 10b5-1 trading plan. F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.82 · Expires 2018-01-01 | Direct | 3,492 |
Reported balance
After 2017-11-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-11-13 · Exercise / conversion · Disposed 9,282 · Balance 3,492 F1: Transaction pursuant to an existing rule 10b5-1 trading plan. F3: This option became fully vested on January 1, 2008 |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.82 · Expires 2018-01-01 | Direct | 0 |
Reported balance
After 2017-11-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-11-14 · Exercise / conversion · Disposed 3,492 · Balance 0 F1: Transaction pursuant to an existing rule 10b5-1 trading plan. F3: This option became fully vested on January 1, 2008 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction pursuant to an existing rule 10b5-1 trading plan.
F2: Includes 3,260 shares subject to deferral pursuant to Issuer's Deferred Equity Plan.
F3: This option became fully vested on January 1, 2008
THERMO FISHER SCIENTIFIC INC.
Report date May 22, 2019 · Filed May 23, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,706 |
Reported balance
After 2019-05-22 transaction · row 1
1 source rowRow 1 · 2019-05-22 · Grant · Acquired 718 · Balance 4,706 |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 3,638 |
Reported balance
Holding disclosure · report date 2019-05-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,638 F1: These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on May 6, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on May 6, 2019.
VERTEX PHARMACEUTICALS INC / MA
Report date June 01, 2019 · Filed June 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $168.04 · Expires 2029-05-31 | Direct | 6,659 |
Reported balance
After 2019-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-01 · Grant · Acquired 6,659 · Balance 6,659 F1: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 2,500 | $0.00 Strike: $11.62 | $0.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 11 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2007-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 10 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2015-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 7,500 | $0.00 Strike: $14.46 | $0.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 9 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2013-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 7,500 | $0.00 Strike: $19.84 | $0.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 8 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2012-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · derivative · entry 7 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2008-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 37,500 | $32.89 | $1,233,375.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 6 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 2,500 | $11.62 | $29,050.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 5 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $13.32 | $133,200.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 4 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,500 | $14.46 | $108,450.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 3 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,500 | $19.84 | $148,800.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 2 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2007 Filed Feb 8, 2007 18:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $14.20 | $142,000.00 |
DisclosureSEC source: 0000875320-07-000023 · edgar.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2006 Filed Jan 4, 2007 22:25 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 644.13 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-07-000002 · ull455.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644.13 Underlying: Common Stock · 644.13 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2006, at a price of $45.41 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on the average of the opening and closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2006, at a price of $45.41 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on the average of the opening and closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2006, at a price of $45.41 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on the average of the opening and closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| November 16, 2006 Filed Nov 20, 2006 21:31 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 13,573 | $43.72 | $593,411.56 |
DisclosureSEC source: 0000097745-06-000233 · ull411.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| November 09, 2006 Filed Nov 15, 2006 01:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 15,600 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0000097745-06-000206 · ull373.xml · derivative · entry 4 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,600 Underlying: Common Stock · 15,600 shares Expires 2013-11-09 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on November 9, 2007. Read SEC document |
| November 09, 2006 Filed Nov 15, 2006 01:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionPhantom Stock Units · Derivative | 13,573.93 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-06-000206 · ull373.xml · derivative · entry 3 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,573.93 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each phantom stock unit was the economic equivalent of one share of TMO common stock. On November 9, 2006, 13,573 of the reporting person's phantom stock units were settled for an equal number of shares of TMO common stock, and the remaining .93 were settled for cash. F1 · price: Each phantom stock unit was the economic equivalent of one share of TMO common stock. On November 9, 2006, 13,573 of the reporting person's phantom stock units were settled for an equal number of shares of TMO common stock, and the remaining .93 were settled for cash. F2 · derivative.exercise_date: November 9, 2006 F2 · derivative.expiration_date: November 9, 2006 Read SEC document |
| November 09, 2006 Filed Nov 15, 2006 01:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Disposition to issuerCommon Stock | 0.93 | $43.37 | $40.33 |
DisclosureSEC source: 0000097745-06-000206 · ull373.xml · nonDerivative · entry 2 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,073 Read SEC document |
| November 09, 2006 Filed Nov 15, 2006 01:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 13,573.93 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-06-000206 · ull373.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,073.93 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each phantom stock unit was the economic equivalent of one share of TMO common stock. On November 9, 2006, 13,573 of the reporting person's phantom stock units were settled for an equal number of shares of TMO common stock, and the remaining .93 were settled for cash. Read SEC document |
| September 30, 2006 Filed Oct 3, 2006 18:33 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 628.97 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-06-000147 · ull329.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,573.93 Underlying: Common Stock · 628.97 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of September 30, 2006, at a price of $39.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 30, 2006, at a price of $39.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 30, 2006, at a price of $39.35 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. Read SEC document |
| July 01, 2006 Filed Jul 5, 2006 17:29 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 638.89 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-06-000132 · ull328.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,944.96 Underlying: Common Stock · 638.89 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of July 1, 2006, at a price of $36.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of July 1, 2006, at a price of $36.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of July 1, 2006, at a price of $36.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. Read SEC document |
| June 01, 2006 Filed Jun 2, 2006 16:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $34.32 | $0.00 |
DisclosureSEC source: 0000875320-06-000047 · edgar.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 20,000 shares Expires 2016-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| May 24, 2006 Filed May 25, 2006 22:03 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 10,500 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0000097745-06-000124 · ull325.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires 2013-05-24 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 24, 2007. Read SEC document |
| April 01, 2006 Filed Apr 4, 2006 19:57 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 708.12 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-06-000087 · ull319.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,306.07 Underlying: Common Stock · 708.12 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of April 1, 2006, at a price of $37.07 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of April 1, 2006, at a price of $37.07 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of April 1, 2006, at a price of $37.07 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. Read SEC document |
| December 31, 2005 Filed Jan 4, 2006 21:52 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 585.04 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-06-000002 · ull302.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,597.95 Underlying: Common Stock · 585.04 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2005, at a price of $30.34 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2005, at a price of $30.34 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2005, at a price of $30.34 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. Read SEC document |
| December 02, 2005 Filed Dec 5, 2005 19:18 UTC Amendment | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 600 | $25.03 | $15,018.00 |
DisclosureSEC source: 0000875320-05-000069 · edgar.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · date: This Form 4 amends the Form 4 filed on behalf of Ms. Ullian on November 28, 2005 to reflect a different transaction date and price. Read SEC document |
| November 28, 2005 Filed Nov 29, 2005 18:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 600 | $25.39 | $15,234.00 |
DisclosureSEC source: 0000875320-05-000067 · edgar.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 37,500 | $26.27 Strike: $11.62 | $985,125.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · derivative · entry 9 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 37,500 shares Expires 2007-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in equal quarterly installment over four years from 12/12/1997. Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $9.09 | $0.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · derivative · entry 8 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,000 Underlying: Common Stock · 7,500 shares Expires 2014-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested on grant date. Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · derivative · entry 7 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 10,000 shares Expires 2009-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested on grant date. Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 37,500 | $26.27 | $985,125.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 6 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 37,500 | $11.62 | $435,750.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 5 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 7,500 | $26.30 | $197,250.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 4 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,500 | $9.09 | $68,175.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 3 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10,000 | $26.27 | $262,700.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 2 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Read SEC document |
| November 15, 2005 Filed Nov 18, 2005 19:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $10.05 | $100,500.00 |
DisclosureSEC source: 0000875320-05-000065 · edgar.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2005 Filed Oct 3, 2005 20:51 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 641.23 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-05-000139 · ull301.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,012.91 Underlying: Common Stock · 641.23 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of October 1, 2005, at a price of $30.80 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of October 1, 2005, at a price of $30.80 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of October 1, 2005, at a price of $30.80 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. Read SEC document |
| July 02, 2005 Filed Jul 6, 2005 18:37 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 689.01 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-05-000107 · ull285.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,371.68 Underlying: Common Stock · 689.01 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of July 2, 2005, at a price of $26.85 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of July 2, 2005, at a price of $26.85 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of July 2, 2005, at a price of $26.85 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. Read SEC document |
| June 01, 2005 Filed Jun 3, 2005 15:08 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0000875320-05-000031 · edgar.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 10,000 shares Expires 2015-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
| May 17, 2005 Filed May 19, 2005 21:10 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0000097745-05-000086 · ull281.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2012-05-17 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 17, 2006. Read SEC document |
| April 02, 2005 Filed Apr 5, 2005 22:13 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 784.04 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000097745-05-000052 · ull267.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,682.67 Underlying: Common Stock · 784.04 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of April 2, 2005, at a price of $25.19 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of April 2, 2005, at a price of $25.19 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of April 2, 2005, at a price of $25.19 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock units based on (a) the average closing price of the stock for the 5 days prior to the end of the quarter with respect to fees and retainers deferred on or prior to December 31, 2004, and (b) the average of the opening and closing price of the stock as of the quarter end with respect to fees and retainers deferred after December 31, 2004. The shares are distributable as stock upon cessation of director service (for any reason), a change of control or, with respect to stock units credited for fees and retainers deferred on or prior to December 31, 2004 only, retirement from principal occupation. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 18:27 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 652.03 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000097745-05-000002 · ull250.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,898.63 Underlying: Common Stock · 652.03 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2004, at a price of $30.29 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2004, at a price of $30.29 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2004, at a price of $30.29 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. Read SEC document |
| October 02, 2004 Filed Oct 4, 2004 20:28 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 709.29 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000097745-04-000160 · ull248.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,246.6 Underlying: Common Stock · 709.29 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of October 2, 2004, at a price of $27.14 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of October 2, 2004, at a price of $27.14 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of October 2, 2004, at a price of $27.14 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. Read SEC document |
| July 03, 2004 Filed Jul 6, 2004 20:43 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 614.01 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000097745-04-000135 · ull245.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,537.31 Underlying: Common Stock · 614.01 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of July 3, 2004, at a price of $30.13 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of July 3, 2004, at a price of $30.13 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of July 3, 2004, at a price of $30.13 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. Read SEC document |
| June 07, 2004 Filed Jun 8, 2004 22:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | PurchaseCommon Stock | 500 | $30.00 | $15,000.00 |
DisclosureSEC source: 0000097745-04-000088 · ull224.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| June 01, 2004 Filed Jun 2, 2004 14:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $9.09 | $0.00 |
DisclosureSEC source: 0000875320-04-000063 · edgar.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 7,500 shares Expires 2014-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
| May 18, 2004 Filed May 20, 2004 21:00 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $28.73 | $0.00 |
DisclosureSEC source: 0000097745-04-000080 · ull220.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2011-05-18 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 18, 2005. Read SEC document |
| April 03, 2004 Filed Apr 6, 2004 20:42 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 720.06 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000097745-04-000044 · ull210.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,923.3 Underlying: Common Stock · 720.06 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of April 3, 2004, at a price of $28.47 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of April 3, 2004, at a price of $28.47 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of April 3, 2004, at a price of $28.47 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 22:34 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 695.27 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000097745-04-000006 · ull197.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,203.24 Underlying: Common Stock · 695.27 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2003, at a price of $25.17 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2003, at a price of $25.17 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2003, at a price of $25.17 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. Read SEC document |
| September 27, 2003 Filed Sep 30, 2003 18:37 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 821.86 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000097745-03-000151 · ull158.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,507.97 Underlying: Common Stock · 821.86 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of September 27, 2003, at a price of $22.51 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 27, 2003, at a price of $22.51 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 27, 2003, at a price of $22.51 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. Read SEC document |
| June 28, 2003 Filed Jun 30, 2003 21:12 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantPhantom Stock Units · Derivative | 646.45 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000097745-03-000109 · ull116.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,686.11 Underlying: Common Stock · 646.45 shares Expires 1988-08-08 F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of June 28, 2003, at a price of $21.27 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of June 28, 2003, at a price of $21.27 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of June 28, 2003, at a price of $21.27 per unit pursuant to the Issuer's exempt Deferred Compensation Plan for Directors (the 'Plan'). Director's fees and retainers are deferred quarterly under the Plan as Common Stock based on the average closing price of the stock for the 5 days prior to the end of the quarter and are distributable as stock upon cessation of director service, death, retirement or a change of control. Read SEC document |
| June 01, 2003 Filed Jun 3, 2003 18:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $14.46 | $0.00 |
DisclosureSEC source: 0000875320-03-000013 · edgar.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,500 Underlying: Common Stock · 7,500 shares Expires 2013-05-31 F1 · derivative.exercise_date: Right to buy under the 1996 Stock and Option Plan. Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.